Pfizer Seeks FDA Approval of COVID Boosters for Children Ages 5-11
WEDNESDAY, April 27, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11. The application hinges on a study of 140 children with no evidence of prior coronavirusContinue Reading